Keynote Presentation: Building Novel Dual-Action CAR-Ts to Effectively Balance Safety & Efficacy
9:30 am - Tuesday 9th February 2027
- Highlighting dual-action CAR targeting the microenvironment and tumour cells
- Targeting macrophages to overcome immunosuppression in solid brain tumours
- Sharing emerging clinical data to evaluate the safety, efficacy, and reliability of CAR-T approaches
